Nonclinical tools update: emerging technologies

IMMUNO-ONCOLOGY INSIGHTS

February 2023

Nonclinical tools update: emerging technologies

Download PDF

Innovator Insight

Assessing efficacy & MoA of mono & combo immunotherapies in preclinical humanized models

Assessing efficacy & MoA of mono & combo immunotherapies in preclinical humanized models

Kader Thiam, Arjun Surya, Edward van der Horst

Interview

Addressing the complexity of the TME with organoids

Addressing the complexity of the TME with organoids

Etienne De Braekeleer

Considering the nonclinical toolkit in I–O: assessing safety, understanding the TME & working towards an animal-free future

Considering the nonclinical toolkit in I–O: assessing safety, understanding the TME & working towards an animal-free future

Kimberly Homan, Aaron Fullerton

Looking for the bigger picture: current challenges & progress in preclinical tools for I–O

Looking for the bigger picture: current challenges & progress in preclinical tools for I–O

Pelin Candarlioglu

27 February 2023

Webinars

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F Boj, Andrea Bisso